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Abstract 
BACKGROUND/OBJECTIVES: Advanced glycation end products (AGEs) contribute to the 
pathophysiology of lifestyle-related diseases. To identify nutrients associated with AGEs, this study 
explored the factors by investigating the relationship between nutrients changes and changes of 
blood AGEs during a weight loss program in obese women. 
SUBJECTS/METHODS: Twenty-five obese women (age: 50 ± 8 years, body mass index: 28.7 ± 
3.4 kg/m2) underwent a weight loss program with energy-restricted meal replacement for 2 
months. Three-day weighted dietary records and blood tests including blood AGEs were 
performed at the baseline and after the 2-month intervention. Their correlation was examined 
during the intervention period. 
RESULTS: The changes in AGEs were significantly and negatively correlated with those of intake 
levels of vitamin D (r = -0.54; P < 0.05). 
CONCLUSION: Vitamin D might be a useful nutrient to reduce AGEs in obese women. 
Key words: AGEs, weight loss, vitamin D. 
Introduction 
Advanced glycation end products (AGEs), 
formed by the Maillard reaction, contribute to the 
development of lifestyle-related diseases [1,2,3]. 
Therefore, the regulation of AGEs is crucial, and 
various environmental factors, such as dietary factors, 
can act to regulate them [4,5,6,7]. However, the 
dietary factors affecting AGEs during a weight loss 
program in subjects without diabetes are unknown. 
Additionally, focusing only on calorie intake during 
weight loss is known to lead to unsatisfactory nutrient 
status. Thus, it is important to examine the nutrients 








Previously, we reported a significant reduction 
in blood AGEs throughout a weight loss program 
using energy-restricted meal replacement [8]; 
however, it did not include an analysis that explored 
nutrients related to blood AGEs. Therefore, the 
purpose of the current study was to explore nutrients 
in relation to changes of blood AGEs among obese 
women as an additional analysis of that study on 
weight loss [8]. 
Subjects and Methods 
Study design 
We conducted exploratory research to identify 
possible nutrients related to blood AGEs. The subjects 
improved their dietary habits by consuming an 
energy-restricted meal replacement instead of their 
regular dinner every day for 2 months, as previously 
described [8]. The study conformed to the ethical 
guidelines of the 2013 Declaration of Helsinki and was 
approved by the Ethics Committee of Kyoto Medical 
Center (Approval No. 06-28). 
Subjects 
The current study involved subjects in whom the 
investigation of nutrients was completely 
unrestricted. Because nutrient intake might have 
different influences on clinical outcomes based on the 
body mass index (BMI), the study involved subjects 
with certain homogeneous characteristics (female and 
obese [BMI of ≥25 kg/m2]) [9]. Thus, 25 obese women 
(mean age: 50.8 ± 8.3 [standard deviation] years, mean 
BMI: 28.7 ± 3.4 kg/m2) were analyzed in the current 
study.  
Diets 
The women consumed an energy-restricted meal 
replacement that contained 5,023 kJ/day, which 
reduced their caloric intake by approximately 20% per 
day, 40% carbohydrate, 7% fat, and 47% protein 
(Diet’s TM; Suntory CO., Ltd., Osaka, Japan) [8], every 
day for 2 months for dinner. A registered dietitian 
instructed each subject on planning a nutritionally 
balanced and constant diet for their other meals, and 
compliance was confirmed through daily dietary 
records [8]. 
Measurements 
We measured the following parameters at the 
baseline and after 2 months of intervention. Height, 
body weight, and BMI were measured. Blood 
pressure was measured using a mercury 
sphygmomanometer. Plasma glucose, total 
cholesterol, triglyceride, and high- and low-density 
lipoprotein cholesterol (LDL-C) levels were 
determined using enzymatic methods. Blood AGEs 
were measured based on the fluorescence intensity 
recorded at 440 nm, upon excitation at 350 nm, using a 
Spectramax Gemini XPS spectrofluorometer with 
Softmax Pro software (Molecular Devices, Sunnyvale, 
California, USA). Average daily energy and nutrient 
intake was estimated by a registered dietitian from 
3-day weighted-food records using Healthy Maker 
Pro501 (Mushroomsoft Co., Ltd., Okayama, Japan). 
Detailed instructions on the use of scales to accurately 
weigh food and drink and record consumption, 
including leftovers, were provided to the subjects. 
Statistical analyses 
Data are expressed as means ± standard 
deviation. The differences between the baseline values 
and those after intervention were analyzed using the 
paired t-test. For a simple correlation analysis, the 
Pearson correlation coefficient was used to determine 
correlations between changes in nutrients and those 
of blood AGEs. A multiple regression analysis model 
for changes in vitamin D intake (dependent variable) 
examined the independence of changes in AGEs, with 
adjustments made for age and changes in body 
weight (basic confounders) or the previous two plus 
changes in dietary fiber intake (a significant factor 
correlated with changes in AGEs in the simple 
correlation analysis). All statistical analyses were 
performed using SPSS program (IBM SPSS 23.0, 




The data at baseline and after intervention are 
presented in Table 1. After intervention, significant 
reductions in weight, blood pressure, plasma glucose, 
LDL-C, and AGEs were observed (these results are 
consistent with those of our previous report [8]). 
Nutrients at baseline and after intervention  
The data on nutrients at baseline and after 
intervention are presented in Table 2. After 
intervention, significant reductions in energy, protein, 
total fat, carbohydrate, vitamin A, thiamin, and salt 
intake were observed (P < 0.05).  
Relationships between changes in dietary 
factors and changes in AGEs 
Changes in blood AGEs were significantly and 
inversely correlated with changes in vitamin D and 
dietary fiber (P < 0.05). A model adjusted for age and 
changes in body weight depicted that this correlation 
was independent of these confounders (β = -0.49, P < 




0.05). An additional model adjusted for the previous 
variables as well as changes in dietary fiber intake 
also depicted this independence (β = -0.47, P < 0.05).  
Discussion 
The current study (as an additional analysis of 
our previous study [8]) revealed that changes in 
vitamin D were negatively correlated with those of 
blood AGEs, which was independent of those of 
weight loss among obese women, during the weight 
loss period. Recently, vitamin D has been indicated to 
exhibit anti-glycation [10,11,12] and anti-oxidation 
(oxidative stress is the final step of the Maillard 
reaction) effects [13,14]. In humans, there have been 
only two AGE studies using high-dosage vitamin D 
[10,12]. Vitamin D supplementation (1,250 μg once 
weekly) reportedly increased serum soluble receptors 
for AGEs (sRAGE) [12], which act as decoys by 
binding to blood AGEs. A vitamin D-fortified (25 
μg/500 mL) yogurt drink decreased blood AGEs after 
3 months [10]. Therefore, the results of this study 
confirmed the previous findings under free feeding 
during weight loss. 
 
Table 1. Baseline characteristics, those after intervention. 
Variables Baseline After intervention Change 
mean (SD) 
Weight (kg) 69.7 (8.1) 65.1 (7.9) -4.6 (1.9) * 
SBP (mmHg) 129.8 (15.9) 124.4 (15.0) -5.4 (10.4) * 
DBP (mmHg) 81.1 (11.5) 75.5 (10.5) -5.6 (7.2) * 
Plasma glucose (mmol/L) 5.06 (0.43) 4.80 (0.39) -0.26 (0.36) * 
Triglycerides (mmol/L) 1.02 (0.47) 0.88 (0.40) -0.14 (0.38)  
HDL-cholesterol (mmol/L) 1.68 (0.37) 1.61 (0.31) -0.07 (0.18)  
LDL-cholesterol (mmol/L) 3.35 (0.69) 3.04 (0.71) -0.31 (0.30) * 
AGEs (AU) 61.0 (9.0) 56.2 (8.8) -4.7 (5.6) * 
Data are mean (standard deviation) 
SBP: systolic blood pressure, DBP: diastolic blood pressure, HDL: high-density lipoprotein, LDL: low-density lipoprotein, AGEs: advanced glycation end 
products. 
The differences between the baseline and after intervention were analyzed using the t-test. *P < 0.05. 
 
Table 2. Baseline nutrients, those after intervention, changes, and correlation between changes in nutrients and changes in AGEs. 
Nutrients Baseline After intervention Change Correlation coefficient 
mean (SD) r 
Energy (kcal) 2,098.9 (454.6) 1,683.1 (461.1) -415.8 (382.5) * -0.16  
Protein (g) 79.7 (17.5) 71.1 (17.5) -8.6 (16.5) * -0.17  
Total fat (g) 71.0 (25.7) 51.6 (1.2) -19.4 (21.6) * -0.11  
Carbohydrate (g) 276.5 (56.9) 231.4 (70.1) -45.1 (56.1) * -0.16  
Dietary fiber (g) 15.8 (4.2) 17.0 (7.5) 1.2 (8.8)  -0.40 * 
Vitamin A (µg) 643.2 (459.6) 564.0 (249.5) -79.2 (494.3) * -0.10  
Vitamin D (µg) 8.5 (6.6) 7.8 (5.1) -0.7 (7.7)  -0.54 * 
Vitamin E (mg) 7.8 (1.8) 7.6 (2.6) -0.1 (3.2)  -0.07  
Vitamin K (µg) 272.8 (138.6) 248.6 (144.0) -24.2 (182.4)  -0.38  
Thiamin (mg) 1.1 (0.4) 1.0 (0.3) -0.2 (0.4) * -0.05  
Riboflavin (mg) 1.3 (0.3) 1.2 (0.4) -0.1 (0.4)  -0.23  
Vitamin B6 (mg) 1.4 (0.3) 1.3 (0.6) 0.0 (0.6)  -0.39  
Vitamin B12 (µg) 7.6 (5.0) 8.1 (5.5) 0.5 (6.7)  -0.02  
Vitamin C (mg) 115.9 (47.8) 122.0 (51.9) 6.1 (57.6)  -0.33  
Salt (g) 10.6 (2.1) 9.7 (2.3) -0.9 (2.2) * 0.13  
Calcium (mg) 576.2 (189.1) 683.2 (529.9) 107.0 (519.0)  -0.04  
Iron (mg) 8.5 (2.0) 8.5 (3.2) 0.0 (3.1)  -0.32  
Data are mean (standard deviation) or correlation coefficient. 
The differences between the baseline and after intervention were analyzed using the t-test. As a simple correlation analysis, the Pearson product-moment 
correlation coefficient was used for the relationship between the changes in nutrients and those of blood AGEs. * P < 0.05. 
 




In this study, we could not identify food 
variables that affect AGEs. Vitamin D is mainly 
included in mushrooms [15] and shellfish [16] in food 
variables. In a partial correlation analysis, we found a 
negative correlation between mushroom ingestion 
and changes in AGEs after adjustment for weight loss 
(P = 0.06) (data not shown). Further studies are 
needed to investigate whether mushrooms can be a 
potential source of vitamin D to reduce AGEs. There 
were certain limitations to the current study, namely a 
relatively small sample size and the blood vitamin D 
concentration was not evaluated.  
In conclusion, the changes in vitamin D were 
negatively correlated with those of blood AGEs, 
independent of the changes of weight loss, during a 
weight loss period among obese women. Further 
studies are warranted to support our results. 
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